Ontology highlight
ABSTRACT:
SUBMITTER: Ayed AO
PROVIDER: S-EPMC7192307 | biostudies-literature | 2018 Oct
REPOSITORIES: biostudies-literature
Ayed Ayed O AO Parikh Sameer A SA
Leukemia & lymphoma 20171108 10
The past two decades have witnessed a paradigm shift in the management of patients with chronic lymphocytic leukemia (CLL), particularly with the introduction of targeted therapies to clinical practice. Ibrutinib is an irreversible inhibitor of Bruton's tyrosine kinase (BTK) and has shown significant efficacy and tolerability, even in heavily treated patients. Despite improvement in outcomes, patients do ultimately relapse. Those who develop disease progression on ibrutinib are a particularly hi ...[more]